ACCURAY INCORPORATED Operating Lease, Right-of-Use Asset, Amortization Expense
ACCURAY INCORPORATED (ARAY) reported Operating Lease, Right-of-Use Asset, Amortization Expense of $5.25 million for the 12-month period ending 2026-06-30, per its 10-K filed 2026-08-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense · last filed 2026-08-27
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for the quarter ending 2026-06-30 was $1.41M, a 260.71% increase year-over-year.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for the quarter ending 2025-09-30 was $1.20M, a 77.22% decline year-over-year.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for the quarter ending 2025-06-30 was $392.00K, a 69.35% decline year-over-year.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for the quarter ending 2025-03-31 was $1.80M, a 30.32% increase year-over-year.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for fiscal 2026 was $5.25M, a 0.61% decline from fiscal 2025.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for fiscal 2025 was $5.28M, a 18.35% decline from fiscal 2024.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for fiscal 2024 was $6.47M, a 20.16% decline from fiscal 2023.
- ACCURAY INCORPORATED operating lease, right-of-use asset, amortization expense for fiscal 2023 was $8.10M, a 12.37% decline from fiscal 2022.
| Period end | Operating Lease, Right-of-Use Asset, Amortization Expense | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month | Operating Lease, Right-of-Use Asset, Amortization Expense 3 month as first filed | Operating Lease, Right-of-Use Asset, Amortization Expense 6 month | Operating Lease, Right-of-Use Asset, Amortization Expense 9 month | Operating Lease, Right-of-Use Asset, Amortization Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $5.25M 10-K · filed 2026-08-27 | ||||
| 2026-03-31 | $3.84M 10-Q · filed 2026-05-06 | |||||
| 2025-12-31 | $2.53M 10-Q · filed 2026-02-17 | |||||
| 2025-09-30 | $1.20M 10-Q/A · filed 2026-02-17 | $1.59M derived: sum of 2 quarters · filed 2026-08-27 | $3.40M derived: sum of 3 quarters · filed 2026-08-27 | $1.20M derived: sum of 4 quarters · filed 2026-08-27 | ||
| 2025-06-30 | $5.28M 10-Q · filed 2026-02-17 | $392.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-27 | $2.20M derived: sum of 2 quarters · filed 2026-08-27 | $5.28M 10-Q · filed 2026-05-06 | $5.28M 10-K · filed 2026-08-27 | |
| 2025-03-31 | $1.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-05-02 | -$392.00K derived: sum of 2 quarters · filed 2025-05-02 | $4.89M 10-Q · filed 2025-05-02 | $6.17M derived: sum of 4 quarters · filed 2026-02-17 | ||
| 2024-12-31 | -$2.20M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2025-02-05 | $3.08M 10-Q · filed 2025-02-05 | $4.36M derived: sum of 3 quarters · filed 2026-02-17 | $5.75M derived: sum of 4 quarters · filed 2026-02-17 | ||
| 2024-09-30 | $5.28M 10-Q/A · filed 2026-02-17 | $1.36M 10-Q · filed 2024-11-06 | $6.56M derived: sum of 2 quarters · filed 2026-02-17 | $7.95M derived: sum of 3 quarters · filed 2026-02-17 | $9.81M derived: sum of 4 quarters · filed 2026-02-17 | |
| 2024-06-30 | $1.28M derived: 10-K/A 12 month − 10-Q 9 month · filed 2026-02-17 | $2.66M derived: sum of 2 quarters · filed 2026-02-17 | $4.53M derived: sum of 3 quarters · filed 2026-02-17 | $6.47M 10-K/A · filed 2026-02-17 | ||
| 2024-03-31 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-08 | $3.25M derived: sum of 2 quarters · filed 2024-05-08 | $5.19M 10-Q · filed 2024-05-08 | $6.90M derived: sum of 4 quarters · filed 2024-09-19 | ||
| 2023-12-31 | $1.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-02-07 | $3.81M 10-Q · filed 2024-02-07 | $5.51M derived: sum of 3 quarters · filed 2024-09-19 | $7.26M derived: sum of 4 quarters · filed 2024-09-19 | ||
| 2023-09-30 | $1.94M 10-Q · filed 2023-11-07 | $3.65M derived: sum of 2 quarters · filed 2024-09-19 | $5.39M derived: sum of 3 quarters · filed 2024-09-19 | $7.83M derived: sum of 4 quarters · filed 2024-09-19 | ||
| 2023-06-30 | $1.71M derived: 10-K 12 month − 10-Q 9 month · filed 2024-09-19 | $3.45M derived: sum of 2 quarters · filed 2024-09-19 | $5.89M derived: sum of 3 quarters · filed 2024-09-19 | $8.10M 10-K · filed 2024-09-19 | ||
| 2023-03-31 | $1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-05-08 | $4.18M derived: sum of 2 quarters · filed 2023-05-08 | $6.39M 10-Q · filed 2023-05-08 | $9.48M derived: sum of 4 quarters · filed 2023-09-07 | ||
| 2022-12-31 | $2.44M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-02-02 | $4.65M 10-Q · filed 2023-02-02 | $7.74M derived: sum of 3 quarters · filed 2023-09-07 | $8.96M derived: sum of 4 quarters · filed 2023-09-07 | ||
| 2022-09-30 | $2.21M 10-Q · filed 2022-11-03 | $5.30M derived: sum of 2 quarters · filed 2023-09-07 | $6.52M derived: sum of 3 quarters · filed 2023-09-07 | $9.34M derived: sum of 4 quarters · filed 2023-09-07 | ||
| 2022-06-30 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-07 | $4.31M derived: sum of 2 quarters · filed 2023-09-07 | $7.13M derived: sum of 3 quarters · filed 2023-09-07 | $9.25M 10-K · filed 2023-09-07 | ||
| 2022-03-31 | $1.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-04-29 | $4.04M derived: sum of 2 quarters · filed 2022-04-29 | $6.16M 10-Q · filed 2022-04-29 | |||
| 2021-12-31 | $2.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-01-28 | $4.94M 10-Q · filed 2022-01-28 | ||||
| 2021-09-30 | $2.12M 10-Q · filed 2021-11-04 | |||||
| 2021-06-30 | $7.19M 10-K · filed 2022-08-17 | |||||
| 2020-06-30 | $7.17M 10-K · filed 2021-08-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Glucotrack, Inc. (GCTK) | United States | $0.027B | |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |
| HeartBeam, Inc. (BEAT) | United States | $0.022B | -2.08 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| RETRACTABLE TECHNOLOGIES INC (RVP) | United States | $0.021B | -6.44 |
| FEMASYS INC (FEMY) | United States | $0.020B | -1.07 |
| Modular Medical, Inc. (MODD) | United States | $0.018B | -0.88 |
| SeaStar Medical Holding Corp (ICU) | United States | $0.015B | -1.14 |
| CERENOME, INC. (CNSY) | United States | $0.014B | |
| Sintx Technologies, Inc. (SINT) | United States | $0.012B | -1.10 |